Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Track 1 : COVID 19 in pharmaceutical

COVID 19 in pharmaceutical

On the pharmaceutical industry, COVID-19 has had a significant impact. For pharmaceutical businesses, it has presented a variety of difficulties and opportunities while also spurring a large amount of research and development.

·         Vaccine Development

·         Antiviral Drug Development

·         Antiviral Drug Development

·         Clinical Trials

·         Pharmacovigilance and Safety Monitoring

·         Research on Long COVID

·         Mental Health Medications

           AI and Data Analytics

Track 2 : Case study and report in pharmaceutical

Case study and report in pharmaceutical

A Pharmaceutical Conference 2023 case study and report typically involve an in-depth analysis of a specific pharmaceutical product, process, or issue. It aims to provide detailed information, insights, and recommendations related to a particular aspect of the pharmaceutical industry.

  • Findings and recommendations
  • Pharmaceutical product or issue

 

Track 3 : Pharmaceutical ethics

Pharmaceutical ethics:

Pharmaceutical ethics, commonly referred to as pharma ethics, is the term used to describe the moral norms and guidelines that guide the conduct and behavior of people and organizations working in the pharmaceutical sector.

Track 4 : Neuropharmaceuticals

Neuropharmaceuticals:

A family of treatments and medicines with a focus on the nervous system's function are referred to as neuropharmaceuticals, sometimes known as neuropsychopharmaceuticals. These medications are used to treat a variety of neurological and mental conditions.

Track 5 : Chemotherapy

Chemotherapy:

Chemotherapy is a medical procedure that uses medications to stop the growth and division of cancer cells inside the body. These medications, also referred to as cytotoxic drugs, target cells that divide fast, including some healthy cells as well as cells that are cancerous.

 

Track 6 : Pharmacognosy

Pharmacognosy:

In the branch of pharmaceutical sciences referred to as pharmacognosy, the study of drugs originating from living things—primarily plants, but also from animals, fungi, and microorganisms—is a key component. In order to understand their therapeutic qualities and prospective medical uses, this field investigates the discovery, a state of isolation description, and analysis of bioactive chemicals from such sources.

Track 7 : Vaccineology

Vaccineology:

The study and practice of vaccination, including its creation, testing, production, and administration as a means of preventing infectious diseases, is the subject of the scientific discipline known as vaccineology.

Track 8 : Psychedelic Medicine

Psychedelic Medicine:

The field of medicine referred to as "psychedelic medicine" studies the therapeutic potential of psychedelic drugs for the treatment of mental illness and other medical disorders. These drugs, which include psilocybin, LSD, and MDMA, are used under well monitored and regulated conditions in clinical settings.

Track 9 : Cosmeceuticals

Cosmeceuticals:

Cosmetics that contain active substances with potential therapeutic advantages are called cosmeticeuticals. They fill the void between cosmetics and drugs by providing goods that not only improve look but also have some medicinal or skincare benefits.

 

Track 10 : Gene therapy

Gene therapy:

Gene therapy is an innovative medical method that includes adding, changing, or removing genetic information from a person's cells in order to treat or prevent diseases brought on by genetic abnormalities or imbalances. It offers the potential to offer specific and durable treatments for a range of hereditary and acquired illnesses.

Track 11 : Pharmacovigilance

Pharmacovigilance:

Pharmacovigilance is the study and practice of keeping an eye on, assessing, and enhancing the security of pharmaceutical goods, particularly after they have been approved and are being used by patients. It entails the gathering, evaluation, and management of data on side effects and other drug-related issues with the intention of reducing risks and encouraging safe and effective medication usage.

Track 12 : Neuropharmacology

Neuropharmacology:

A subfield of pharmacology called neuropharmacology studies how drugs and therapies affect the neurological system, including both the central and peripheral nerve systems, and tries to understand the mechanisms of action, therapeutic uses, and potential adverse effects.

 

Track 13 : Safety pharmacology

Safety pharmacology:

Safety pharmacology is a branch of pharmacology that focuses on the assessment and evaluation of the potential side effects and safety profile of drugs and pharmaceutical compounds. It primarily aims to ensure the safety of these substances during early development stages and throughout their use in clinical trials and in the general population.

Track 14 : Drug Formulation

Drug Formulation:

Drug formulation, which involves multidisciplinary efforts to design and produce secure and efficient treatments for a variety of medical diseases, is a crucial component of the pharmaceutical industry. It combines elements of chemistry, pharmacology, materials science, and regulatory compliance in order to introduce novel and enhanced medications to the market.

Track 15 : Radiopharmacology

Radiopharmacology:

The study of radiopharmaceuticals, or medications containing radioactive materials, is the subject of the specialist discipline known as radiopharmacology. For both diagnostic and therapeutic purposes, these chemicals are employed in nuclear medicine. The manufacture, properties, disposition, and clinical applications of radiopharmaceuticals are examined in radiopharmacology.

Track 16 : Clinical trials

Clinical trials:

Clinical trials are research projects using human subjects that assess the efficacy, safety, and potential negative consequences of novel medical interventions, such as medications, therapies, technologies, and vaccines. These studies are vital to the development of medical knowledge, the enhancement of patient care, and ultimately the introduction of novel medical goods.